For research use only. Not for therapeutic Use.
Enlimomab（Cat No.:M093042）is a monoclonal antibody designed to target and inhibit the tumor necrosis factor-alpha (TNF-α) receptor. TNF-α is a cytokine involved in inflammation and immune responses, and its overexpression is associated with various autoimmune diseases and inflammatory conditions. By blocking TNF-α activity, Enlimomab may help reduce inflammation and alleviate symptoms in conditions such as rheumatoid arthritis and Crohn’s disease. Although it showed potential in early clinical trials, further research and testing were required to assess its safety and efficacy for widespread use in treating inflammatory disorders.
| Catalog Number | M093042 |
| CAS Number | 142864-19-5 |
| Purity | ≥95% |
